Metabolic syndrome: Evidences for a personalized nutrition

Molecular Nutrition and Food Research - Tập 56 Số 1 - Trang 67-76 - 2012
Pablo Pérez‐Martínez1,2, Antoni Sureda1,2, Javier Delgado‐Lista1, Francisco Pérez‐Jiménez1, José López‐Miranda1
1Lipid and Atherosclerosis Unit, IMIBIC/Reina Sofia University Hospital/University of Cordoba, and CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Spain
2these authors contributed equally to this work

Tóm tắt

Abstract

Both insulin resistance and dyslipidaemia are determined by genetic and environmental factors. Depending on their expression and their function, gene variants may influence either insulin action or other metabolic traits. Nutrition also plays an important role in the development and progression of these conditions. Genetic background may interact with habitual dietary fat composition, affecting predisposition to insulin resistance syndrome and individual responsiveness to changes in dietary fat intake. In this context, nutrigenetics has emerged as a multidisciplinary field focusing on studying the interactions between nutritional and genetic factors and health outcomes. Due to the complex nature of gene–environment interactions, however, dietary therapy may require a “personalized” nutrition approach in the future. Although the results have not always been consistent, gene variants that affect primary insulin action, and particularly their interaction with the environment, are important modulators of glucose metabolism. The purpose of this review is to present some evidence of studies that have already demonstrated the significance of gene–nutrient interactions (adiponectin gene, Calpain‐10, glucokinase regulatory protein, transcription factor 7‐like 2, leptin receptor, scavenger receptor class B type I etc.) that influence insulin resistance in subjects with metabolic syndrome.

Từ khóa


Tài liệu tham khảo

10.1161/01.CIR.0000019884.36724.D9

10.1016/j.jacc.2005.11.046

10.1210/er.2008-0024

10.1079/PNS2005445

10.1007/s00109-006-0138-1

10.1097/00041433-200404000-00002

10.1157/13115358

10.2174/138161211795428948

10.1016/S0140-6736(04)17663-0

10.1161/CIRCULATIONAHA.107.716159

10.1001/archinte.168.22.2449

10.1016/j.numecd.2008.10.007

10.2337/dc06-2220

10.1016/j.jacc.2010.09.073

10.1080/07315724.2008.10719713

10.3945/jn.110.124297

10.1056/NEJMoa012918

10.1016/j.atherosclerosis.2011.07.003

10.3945/ajcn.110.005603

10.1146/annurev.med.091708.162036

10.1111/j.1749-6632.2010.05838.x

10.1007/s11883-010-0100-0

10.1016/j.numecd.2009.04.018

10.1097/MOL.0b013e3283292399

10.1097/MCG.0b013e3181dd8b64

10.2337/diabetes.54.7.1899

10.1016/S0958-1669(00)00256-1

10.1079/BJN20051585

GOLDN.Genetics of lipid lowering drugs and diet network. [Accessed March 12 2008].

10.1017/S0007114508039962

10.1038/90992

10.1038/nm788

10.2337/diabetes.52.2.239

10.1253/circj.68.975

10.1210/jcem.86.5.7463

10.1093/hmg/11.21.2607

10.1017/S1462399406000147

10.1038/90984

10.2337/db06-0506

10.1016/S1673-8527(08)60047-8

10.1093/jn/138.9.1609

10.3945/ajcn.2009.28255

10.1038/oby.2008.583

10.3945/ajcn.111.014209

10.1371/journal.pone.0002953

10.1016/j.diabres.2004.09.015

10.1210/jc.2003-032105

10.1016/S0009-8981(03)00320-6

10.2337/diabetes.51.1.231

10.3945/ajcn.110.010512

10.2337/diabetes.48.10.2022

10.3945/ajcn.2008.26363

10.2337/db08-0516

10.1371/journal.pone.0020555

10.2337/dc10-1150

10.1007/s00439-009-0700-3

10.1126/science.289.5481.950

10.1056/NEJMoa062418

10.1007/s00125-008-1025-9

10.1055/s-2007-957345

10.1016/j.atherosclerosis.2010.10.027

10.1016/j.jnutbio.2010.11.020

10.1126/science.271.5248.518

10.1677/jme.0.0320237

10.1093/jn/137.3.578

10.1093/ajcn/77.4.809

10.1210/jc.2004-1489

10.1074/jbc.M800029200

10.1097/01.mol.0000162319.54795.e5

10.1007/s00439-006-0167-4

10.2337/diabetes.53.10.2676

10.3945/jn.108.101196

10.1902/jop.2008.080232

10.1016/j.mrfmmm.2008.10.018

10.1007/s00109-006-0138-1

10.1097/01.hco.0000221579.25878.11

10.1159/000112461

10.1016/j.atherosclerosis.2010.10.029

10.3945/jn.109.109900

10.1210/jc.2009-1081

10.3945/ajcn.2009.27536

10.3945/ajcn.2009.28101

10.3945/jn.109.115329

10.1093/aje/kwq281

10.1038/sj.ijo.0803450

10.1016/j.atherosclerosis.2010.03.027

10.1194/jlr.M008474

10.1194/jlr.M003046

10.3945/jn.109.110635